• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Audio Journal of Infectious Disease: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco

0
  • by alexperjescuadmin
  • in Public Health
  • — 29 Sep, 2006
Audio Journal of Infectious Disease: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
AudioMedica News
Audio Journal of Infectious Disease: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
Audio Journal of Infectious Disease: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
00:00 /
RSS Feed
Share
Link
Embed
Henry Fraimow
Henry Fraimow
Michael Jacobs
Michael Jacobs
Ron Dagan
Ron Dagan

MRSA: Not Only Carried in the Nose

REFERENCE: Abstract C2-605
Henry Fraimow, Cooper University Hospital, Camden, New Jersey
Methicillin resistant Staphylococcus aureus is most often looked for in the nose, but could it be hiding elsewhere? According to Henry Fraimow, of Cooper University Hospital in Camden, New Jersey, vaginal and rectal cavities may also be an important reservoirs for this bacterium. Derek Thorne asked him about his findings.

Pneumococcal Vaccine Selects for Multidrug Resistant S. Pneumoniae Serotype

REFERENCE: Abstract G-346
Michael Jacobs, Case Western Reserve University, Cleveland
The conjugated pneumococcal vaccine did initially reduce the incidence of invasive Streptococcus pneumoniae infection in children; however, six years after its introduction, a particular multidrug resistant serotype has replaced the types that were covered by the vaccine. Michael Jacobs of the Case Western Reserve University, Cleveland, revealed his findings to the ICAAC conference and talked about them in San Francisco with Derek Thorne.

Decrease in Antibiotic Use Leads to Decrease in Resistant S. pneumoniae

REFERENCE: Abstract G-345
Ron Dagan, Soroka University Medical Center, Beer-Sheva, Israel
If antibiotic use drops markedly, will resistant strains become less common? Have they paid a ‘fitness cost’ in becoming resistant? A group led by Ron Dagan, of the Soroka University Medical Center in Beer-Sheva, Israel, tested this hypothesis by tracking Streptococcus pneumoniae strains throughout the year, to see whether a decrease in antibiotics – which is seen in the summer months – led to a decrease in resistant strains. During the ICAAC meeting he told Derek Thorne about their findings.

[audio:https://www.audiomedica.com/podcasting/infectious/060929icaac.mp3]
Share

Tags: antibioticbacteriumdiseaseinfectiousMRSApneumococcalpneumoniaeserotypeStreptococcusvaccine

You may also like...

  • Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study 19 Jan, 2007
  • Nuclear War: The Facts Today Nuclear War: The Facts Today 9 Feb, 2017
  • Hugh Reyburn Lab In A Box Fights Malaria In The Villages 12 Nov, 2011
  • Building Health For All Capacity In Tanzania Building Health For All Capacity In Tanzania 30 Mar, 2012

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Audio Journal of Global Health Issues: Tipranavir Brings Hope for HIV-1 Patients Resistant to Standard Antiretorviral Therapy
  • Next story Audio Journal of Global Health Issues: Smoking Inequalities Explain Half the Mortality Differences Between Men of Different Socioeconomic Groups
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with…
    • CT Screening Cuts Lung Cancer Deaths 24 Per…
  • Home
  • Public Health
  • Audio Journal of Infectious Disease: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.